Saudi Arabia Sepsis Diagnostics Market Size & Outlook

The sepsis diagnostics market in Saudi Arabia is expected to reach a projected revenue of US$ 14.5 million by 2030. A compound annual growth rate of 8.2% is expected of Saudi Arabia sepsis diagnostics market from 2023 to 2030.
Revenue, 2022 (US$M)
$7.7
Forecast, 2030 (US$M)
$14.5
CAGR, 2023 - 2030
8.2%
Report Coverage
Saudi Arabia

Saudi Arabia sepsis diagnostics market, 2018-2030 (US$M)

Saudi

Saudi Arabia sepsis diagnostics market highlights

  • The Saudi Arabia sepsis diagnostics market generated a revenue of USD 7.7 million in 2022 and is expected to reach USD 14.5 million by 2030.
  • The Saudi Arabia market is expected to grow at a CAGR of 8.2% from 2023 to 2030.
  • In terms of segment, blood culture media was the largest revenue generating product in 2022.
  • Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.


Sepsis diagnostics market data book summary

Market revenue in 2022USD 7.7 million
Market revenue in 2030USD 14.5 million
Growth rate8.2% (CAGR from 2022 to 2030)
Largest segmentBlood culture media
Fastest growing segmentAssay Kits & Reagents
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Blood Culture Media, Assay Kits & Reagents, Software
Key market players worldwideBD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress


Other key industry trends

  • In terms of revenue, Saudi Arabia accounted for 0.8% of the global sepsis diagnostics market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, Saudi Arabia sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 14.5 million by 2030.

Blood culture media was the largest segment with a revenue share of 38.96% in 2022. Horizon Databook has segmented the Saudi Arabia sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.


The sepsis diagnostics market in Saudi Arabia is driven by the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases. According to a study published by the National Library of Medicine in April 2024, brucellosis, tuberculosis, and salmonellosis are the most frequently reported bacterial infections in Saudi Arabia.

The study found that brucellosis and tuberculosis primarily impact males, while salmonellosis is more common among Saudi citizens. The government’s Vision 2030 initiative is significantly enhancing healthcare infrastructure, leading to improved diagnostic capabilities. In addition, pulmonary tuberculosis is notably more prevalent among non-Saudi residents.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Sepsis Diagnostics Market Companies

Name Profile # Employees HQ Website

Saudi Arabia sepsis diagnostics market size, by product, 2018-2030 (US$M)

Saudi Arabia Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)

Saudi Arabia sepsis diagnostics market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more